ClinVar Miner

Submissions for variant NM_014363.6(SACS):c.9286G>A (p.Ala3096Thr)

dbSNP: rs1085307569
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000489327 SCV000576738 uncertain significance not provided 2017-04-20 criteria provided, single submitter clinical testing The A3096T variant in the SACS gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The A3096T variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The A3096T variant is a non-conservative amino acid substitution, which occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret A3096T as a variant of uncertain significance.
Natera, Inc. RCV001829396 SCV002086197 uncertain significance Charlevoix-Saguenay spastic ataxia 2020-12-17 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.